Showing results (1-10 of 393) with videos related to
Sort By:
Pageof 40
Current Cancer Drug Targets|February 20, 2007
Costimulation, coinhibition and cancerBrant A Inman, Xavier Frigola, Haidong Dong, et al.Cancer|March 7, 2007
PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progressionBrant A Inman, Thomas J Sebo, Xavier Frigola, et al.Immunology Letters|December 6, 2011
Soluble B7-H1: differences in production between dendritic cells and T cellsXavier Frigola, Brant A Inman, Christopher J Krco, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2011
Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinomaXavier Frigola, Brant A Inman, Christine M Lohse, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccineW Scott Webster, R Houston Thompson, Kimberley J Harris, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2008
Questionable relevance of gamma delta T lymphocytes in renal cell carcinomaBrant A Inman, Xavier Frigola, Kimberley J Harris, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 28, 2009
TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccinationVesna Pulko, Xin Liu, Christopher J Krco, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapyR Houston Thompson, Haidong Dong, Eugene D KwonCancer Research|August 10, 2007
B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapyTimothy J Roth, Yuri Sheinin, Christine M Lohse, et al.Current Urology Reports|April 21, 2015
Immunotherapy in prostate cancerIlya Sobol, R H Thompson, Haidong Dong, et al.Pageof 40